You are here » Home » Company » Natco Pharma Ltd

Natco Pharma Ltd.

BSE: 524816 Sector: Health care
NSE: NATCOPHARM ISIN Code: INE987B01026
BSE 00:00 | 15 Jan 691.55 7.35
(1.07%)
OPEN

686.00

HIGH

693.45

LOW

686.00

NSE 00:00 | 15 Jan 692.70 7.20
(1.05%)
OPEN

685.50

HIGH

694.70

LOW

685.50

OPEN 686.00
PREVIOUS CLOSE 684.20
VOLUME 4447
52-Week high 1045.95
52-Week low 637.40
P/E 14.26
Mkt Cap.(Rs cr) 12,769
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 686.00
CLOSE 684.20
VOLUME 4447
52-Week high 1045.95
52-Week low 637.40
P/E 14.26
Mkt Cap.(Rs cr) 12,769
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Natco Pharma Ltd.

Natco Pharma Ltd

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company's focus is primarily on niche therapeutic areas and complex products. The company sells its products in over 40 countries. FDF products are sold in the United States I...> More

Natco Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   12,769
EPS - TTM () [*S] 48.48
P/E Ratio (X) [*S] 14.26
Face Value ()   2
Latest Dividend (%)   75.00
Latest Dividend Date 20 Aug 2018
Dividend Yield (%) 1.19
Book Value / Share () [*S] 188.75
P/B Ratio () [*S] 3.66
[*C] Consolidated     [*S] Standalone    

Natco Pharma Ltd - Financial Results

Particulars ( cr) Sep 2018 Sep 2017 % Chg
Net Sales 543.5 426.7 27.37
Other Income 40 5.5 627.27
Total Income 583.5 432.2 35.01
Total Expenses 323 304.8 5.97
Operating Profit 260.5 127.4 104.47
Net Profit 181.6 84.4 115.17
Equity Capital 36.9 34.9 -
> More on Natco Pharma Ltd Financials Results

Natco Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Glenmark Pharma. 665.90 -0.07 18791.70
Abbott India 8106.95 0.96 17227.27
Sanofi India 6228.20 -0.81 14343.55
Natco Pharma 691.55 1.07 12769.47
Pfizer 2698.30 0.07 12344.72
Jubilant Life 716.15 -0.78 11408.27
Alembic Pharma 599.60 0.23 11302.46
> More on Natco Pharma Ltd Peer Group

Natco Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 48.43
Banks/FIs 0.70
FIIs 23.82
Insurance 0.00
Mutual Funds 5.13
Indian Public 17.74
Custodians 0.00
Other 3.93
> More on Natco Pharma Ltd Share Holding Pattern

Natco Pharma Ltd - Research Reports

Date Broker Action Price Report
07/11 Equirus Securities Accumulate 957 PDF IconDetails
> More on Natco Pharma Ltd Research Reports

Natco Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -0.30% -0.50% 0.94% 0.78%
1 Month -1.28% -1.24% 0.99% 0.75%
3 Month -3.56% -3.44% 4.17% 3.56%
6 Month -13.25% -13.26% -0.61% -1.20%
1 Year -33.26% -33.12% 4.23% 1.35%
3 Year 30.38% 30.37% 48.51% 46.37%

Natco Pharma Ltd - STOCK STRENGTH

Today's Low/High 686.00
693.45
Week Low/High 680.90
700.00
Month Low/High 666.40
717.00
YEAR Low/High 637.40
1046.00
All TIME Low/High 1.60
1080.00